A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID ‐19: Will cases of psoriasis increase after COVID ‐19 pandemic?

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China

(2020) Zunyou Wu et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

(2020) Chaolin Huang et al.   LANCET

The COVID‐19 epidemic

(2020) Thirumalaisamy P. Velavan et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools

(2020) Yajing Fu et al.   VIROLOGICA SINICA

COVID‐19 and psoriasis: is it time to limit treatment with immunosuppressants? A call for action

(2020) Claudio Conforti et al.   Dermatologic Therapy

Treating COVID-19—Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics

(2020) Andre C. Kalil   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Chloroquine Promotes IL-17 Production by CD4+T Cells via p38-Dependent IL-23 Release by Monocyte-Derived Langerhans-like Cells

(2014) André Said et al.   JOURNAL OF IMMUNOLOGY